Insider Transactions in Q1 2022 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2022
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
210
-0.69%
|
$8,820
$42.55 P/Share
|
|
Feb 18
2022
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
637
+2.05%
|
-
|
|
Feb 18
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-0.35%
|
$25,872
$42.55 P/Share
|
|
Feb 18
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
1,779
+1.0%
|
-
|
|
Feb 18
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
510
-3.5%
|
$21,420
$42.55 P/Share
|
|
Feb 18
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,037
+6.64%
|
-
|
|
Feb 18
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
2,354
-55.55%
|
$98,868
$42.88 P/Share
|
|
Feb 18
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
784
-15.61%
|
$32,928
$42.55 P/Share
|
|
Feb 18
2022
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,668
+34.69%
|
-
|
|
Feb 18
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
327
-1.48%
|
$13,734
$42.55 P/Share
|
|
Feb 18
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,112
+4.8%
|
-
|
|
Feb 18
2022
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-1.01%
|
$15,246
$42.55 P/Share
|
|
Feb 18
2022
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,186
+3.21%
|
-
|
|
Feb 18
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,125
-1.21%
|
$47,250
$42.55 P/Share
|
|
Feb 18
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,001
+2.11%
|
-
|
|
Feb 17
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,033
-0.75%
|
$85,386
$42.83 P/Share
|
|
Feb 17
2022
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,583
+1.66%
|
-
|
|
Feb 17
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-1.06%
|
$13,944
$42.83 P/Share
|
|
Feb 17
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+3.1%
|
-
|
|
Feb 17
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,185
-3.58%
|
$49,770
$42.83 P/Share
|
|
Feb 17
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+7.89%
|
-
|
|
Feb 17
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
661
-0.41%
|
$27,762
$42.83 P/Share
|
|
Feb 17
2022
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+1.37%
|
-
|
|
Feb 17
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
441
-1.84%
|
$18,522
$42.83 P/Share
|
|
Feb 17
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.88%
|
-
|
|
Feb 17
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,056
-0.96%
|
$86,352
$42.83 P/Share
|
|
Feb 17
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+1.91%
|
-
|
|
Feb 17
2022
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-2.36%
|
$34,944
$42.83 P/Share
|
|
Feb 17
2022
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+7.44%
|
-
|
|
Feb 17
2022
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,131
-0.38%
|
$341,502
$42.83 P/Share
|
|
Feb 17
2022
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,333
+0.86%
|
-
|
|
Feb 17
2022
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
367
-1.12%
|
$15,414
$42.83 P/Share
|
|
Feb 17
2022
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+3.66%
|
-
|
|
Feb 17
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,020
-0.74%
|
$42,840
$42.83 P/Share
|
|
Feb 17
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+2.36%
|
-
|
|
Feb 17
2022
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
350
-1.16%
|
$14,700
$42.83 P/Share
|
|
Feb 17
2022
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+3.2%
|
-
|
|
Feb 17
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
750
-0.43%
|
$31,500
$42.83 P/Share
|
|
Feb 17
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
2,166
+1.22%
|
-
|
|
Feb 17
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
713
-5.0%
|
$29,946
$42.83 P/Share
|
|
Feb 17
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,416
+9.03%
|
-
|
|
Feb 17
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
979
-29.37%
|
$41,118
$42.83 P/Share
|
|
Feb 17
2022
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Feb 17
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
494
-2.3%
|
$20,748
$42.83 P/Share
|
|
Feb 17
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,583
+6.87%
|
-
|
|
Feb 17
2022
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
459
-1.31%
|
$19,278
$42.83 P/Share
|
|
Feb 17
2022
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.1%
|
-
|
|
Feb 17
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,406
-1.53%
|
$59,052
$42.83 P/Share
|
|
Feb 17
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.64%
|
-
|
|
Feb 16
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
12,187
-4.38%
|
$524,041
$43.7 P/Share
|